Estimating the starting dose for entry into humans: principles and practice Bruno G. ReignerKaren Blesch Review Article 29 January 2002 Pages: 835 - 845
Inhibitory effects of H1-antihistamines on CYP2D6- and CYP2C9-mediated drug metabolic reactions in human liver microsomes Nu HeWen-Qi ZhangTimi Edeki Pharmacokinetics and Disposition 17 January 2002 Pages: 847 - 851
Paracetamol disposition in renal allograft recipients U. MartinR. TempleL. Prescott Pharmacokinetics and Disposition 19 January 2002 Pages: 853 - 856
N-acetyltransferase 2 polymorphism in sporadic Parkinson's disease in a Polish population Monika BialeckaBarbara Gawronska-SzklarzJan Stankiewicz Pharmacokinetics and Disposition 23 January 2002 Pages: 857 - 862
No clinically relevant drug interaction between paracetamol and phenprocoumon based on a pharmacoepidemiological cohort study in medical inpatients Karin FattingerRoberto FrisulloMalgorzata Roos Pharmacokinetics and Disposition 23 January 2002 Pages: 863 - 867
Pharmacokinetics and non-analgesic effects of S- and R-ketamines in healthy volunteers with normal and reduced metabolic capacity J. PerssonJ. HasselströmO. Almqvist Pharmacokinetics and Disposition 08 December 2001 Pages: 869 - 875
The pharmacokinetics of ketobemidone are not affected by CYP2D6 or CYP2C19 phenotype Ayman Al-ShurbajiJuliette Säwe Pharmacokinetics and Disposition 29 January 2002 Pages: 877 - 881
A pharmacokinetic and pharmacodynamic model for intravenous bisphosphonate (pamidronate) in osteoporosis Serge CremersRolf SparidansSocrates Papapoulos Pharmacokinetics and Disposition 29 January 2002 Pages: 883 - 890
Heavy metals in traditional Indian remedies E. Ernst Pharmacoepidemiology and Prescription 08 December 2001 Pages: 891 - 896
Quality and impact of problem-oriented drug information: a method to change clinical practice among physicians? Jan SchjøttErik PompAne Gedde-Dahl Pharmacoepidemiology and Prescription 21 November 2001 Pages: 897 - 902
Descriptive study and pharmacotherapeutic intervention in patients with epilepsy or Parkinson's disease at nursing homes in southern Sweden Patrik MidlövÅsa BondessonPeter Höglund Pharmacoepidemiology and Prescription 29 January 2002 Pages: 903 - 910
Forged medical prescriptions in a community pharmacy network in Midi-Pyrénées area: assessment of a falsification ratio M. LlauM. Lapeyre-MestreJ. Montastruc Pharmacoepidemiology and Prescription 29 January 2002 Pages: 911 - 912
A double-blind comparison of the bronchodilatory effect of cumulative doses of salbutamol from Diskus (Accuhaler) and Turbuhaler Per M. Gustafsson Letter to the Editors 01 February 2002 Pages: 913 - 914
Significant reduction of sertraline plasma levels by carbamazepine and phenytoin Maria PihlsgaårdErik Eliasson Letter to the Editors 23 January 2002 Pages: 915 - 916
Heparin “hitts” again Federico GotiWolfgang KorteMarco Decurtins Letter to the Editors 29 January 2002 Pages: 917 - 918
Evaluation of isolated case reports on hepatotoxicity Simona GattiMario Bertazzoli Letter to the Editors 29 January 2002 Pages: 919 - 920
Letter to the editor by Drs. Gatti and Bertazzoli entitled “Evaluation of isolated case reports on hepatotoxicity” Karin FattingerGerd A. Kullak-Ublick Reply 29 January 2002 Pages: 921 - 922